Opalia Pharma's Corporate Majority Round

Opalia Pharma raised a round of funding on October 31, 2013. Investors include Recordati.

Opalia Pharma markets branded generic drugs with leading products in dermatology and in the gastrointestinal and respiratory therapeutic areas. Opalia manufactures most of its products in a modern, cG…

Articles about Opalia Pharma's Corporate Majority Round: